Glaxis Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,000	Closed	-$760K	–	34
2017 Q3	$760K	Buy	+5,000	New	+$760K	1.16%	14
2013 Q4	–	Sell	-10,600	Closed	-$804K	–	50
2013 Q3	$804K	Buy	+10,600	New	+$804K	1.62%	25